Member Info for ShareSting

This is excellent news today.
After people moaning about Richard’s body language (how desperate) yesterday, it good to see a more positive forward looking chatroom today.

The Roche Gilead combo is just another combo trial. I remember reading the Remdesivir drug trial was stopped because of an increase in death in patients taking it. It is also only approved for servers C-19 symptoms, so it really limits use.

Overall as a investor and not a trader I can’t wait to see the results of 15 years research and development. Very exciting times for Synairgen. This is a drug not a test and valuations if ( yes I said if) successful will be +£1 billion IMO.

DYOR, I have !

We should see allot of delayed trades posted later.

Jakeman59. Best post of the day !!

Will ODX finish red ??

Well just as well Synairgen has COPD results due as well then. Sorry as an investor my glass is half full.

Right back at ya fellow investor!

Ghia I missed that !
What a ramper ! Have they bought in ;-)

Haha
My mind is very open as is my wallet at this level !
As an investor I so the pro’s and con’s of investing my hard earned money... unlike some that just can’t see past the negatives... oh and I’m more of a Yorkie guy !

Such a shame the amazing news is being overshadowed by the pure spite and anger of the resident trolls. The board used to be full of sensible debate (positive and negative).
Time to switch off for the day.

OMG how can anyone claim one treatment is doing better than another. Who can claim page spreads in national newspapers is low key. Who can claim that designing the first ever home clinical study is low key. Who can claim the drug is 100% all about C-19 when just yesterday they confirmed they are opening the COPD data (which is a multi billion industry). Who can claim that... yes an uninformed troll. Time to filter Seb46 me thinks !!’

Looks like today is the day for traders to depart and trolls to go into overdrive.
Traders will be back. They are not expecting anything until July. That might be a little short sited, as we know other news could land any day.

Anyhow I have taken advantage of the drop. I also expect to see some large buys appear later today !!

COPD results will make this company. C-19 results will be the icing and cherry - if successful.

The best in the UK is working on this project, I trust them over any troll !!

I kinda of agree.
We have learnt allot more around the home trials as well. Patient demographics, 40 mile radius....

The COPD news for me is the most exciting and it will allow the major multinational drug companies a early look at the results prior to the partnership discussions ( chairman confirmed multinationals were interested in Sept19 RNS)

How can anyone compare cost of treatment at this stage , Greenfish? Especially when we don’t know when and how the treatments will be given. As for your comment on Cytokine storm, this has been covered around 6 weeks ago
When the original report came out.

As for usage of SNG001, as detailed in the September 2019 chairman comments this is potentially allot wider than just Asthma, COPD and Covid19!!

If you are a trader you will be highly frustrated today.
If you are a investor, boy you should be excited (even though some will call you a ramper).

More national press. Fantastic exposure.
COPD data opening early - massive news / billion dollar market.
Novel Covid19 trials start. Company had to write the protocols for this trial. Amazing achievement in such a short space of time.
Covid Hospital trials closing very soon. Again only placebo trial ending this quickly.

You know it’s so easy to be critical on timelines slipping, but in the real world of drug development, the team at Synairgen are on hypodrive. They have performed amazingly over the last 3 months.

In the interest of balance, nothing is guaranteed... but boy it’s getting exciting!

GLA.

“Board is full of useless ramping”. Oh dear.
The board is full of loyal investors that are working off two RNS’s which updates the market today. I doubt you have read the Chairman’s statement in full.

Everyone is entitled to his or her opinion, but please don’t call genuine investors rampers... that is a sign of true desperation on your behalf.

If you are complaining that the trials have been moved back you need to know that most trials take years to deliver not months. Don’t blame the CEO, he has world magic over the last 3 months.

Why does it worry you ?

why Focus on the price today, if you are invested long term.
Yes traders will be disappointed they can’t flip more shares, buy investors should be delighted with the outstanding progress and update announced today. So if you are a trader, maybe this is not the right share for you ??

Morning all

These were two milestone RNS’s today.
Very happy with the progress.
Anyone involved in the industry will know how regulated and complex it is to run clinical studies. We have the results of three in two months.
More importantly the medical world will be all over this. How anyone can be upset after today’s announcement is beyond me. Just research the COPD market alone !!

Nolupus

Thank you for the findings. Very exciting to see another drug performing in the fight against Covid19.
As you know the world will need a number of treatments to fight Covid19. I think last weekend you focussed on a Vaccine company and again thank you for bringing that to our attention. Your research into every drug but the one you are invested in is so valuable.

I am sure you will be getting excited about the potential for SNG001 to step up in the fight against Covid19. However as I am sure you are aware, for SNG001 it’s not just about Covid19, it’s also about COPD, Asthma and four other sectors highlighted as potential suitable targets to use SNG001.